Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001437749-15-012313)

Filing Details

Accession Number:: 0001437749-15-012313
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2015-06-15 16:18:28
Reporting Period:: 2015-06-09

Filing Date:: 2015-06-15
Accepted Time:: 2015-06-15 16:18:28
Original Submission Date:: 2015-06-11
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
72444	Biota Pharmaceuticals Inc.	BOTA	Biological Products, (No Disgnostic Substances) (2836)	591212264

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1500591	James Fox	2500 Northwinds Parkway Ste 100 Alpharetta GA 30009		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-06-10	70,000	$2.03	100,614	No	4	P	Indirect	Penashe Holdings Pty Ltd.

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	Penashe Holdings Pty Ltd.

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	8,700	Direct

Footnotes

Mr. Fox is an executive director of Penashe Holdings Propriety Limited and may be deemed to have beneficial ownership of these securities to the extent of any indirect pecuniary interest in his distributive shares therein.
The original Form 4 report filed on June 11, 2015 incorrectly reported the purchase date and price of the purchase and excluded the direct holdings of the reporting person.